nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—Gefitinib—CHEK2—bone cancer	0.267	0.647	CrCbGaD
Minaprine—Gefitinib—EGFR—bone cancer	0.107	0.259	CrCbGaD
Minaprine—Gefitinib—CYP3A4—bone cancer	0.039	0.0944	CrCbGaD
Minaprine—DRD2—GPCR ligand binding—GRM4—bone cancer	0.00227	0.00386	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—GRM4—bone cancer	0.00223	0.0038	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—GRM1—bone cancer	0.00223	0.00379	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—GRM4—bone cancer	0.00222	0.00378	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.00221	0.00376	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.0022	0.00374	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—CDK4—bone cancer	0.00218	0.00371	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—TUBB2A—bone cancer	0.00208	0.00355	CbGpPWpGaD
Minaprine—ACHE—Metabolism—NDUFA12—bone cancer	0.00207	0.00353	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00197	0.00336	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—GRM1—bone cancer	0.00196	0.00335	CbGpPWpGaD
Minaprine—MAOA—Metabolism—NDUFA12—bone cancer	0.00195	0.00333	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—SMO—bone cancer	0.00194	0.00331	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—GRM1—bone cancer	0.00193	0.00329	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—GRM1—bone cancer	0.00192	0.00328	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—SMO—bone cancer	0.00183	0.00312	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—GRM4—bone cancer	0.0018	0.00306	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—RGS1—bone cancer	0.0018	0.00306	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—CDK4—bone cancer	0.00176	0.003	CbGpPWpGaD
Minaprine—ACHE—Metabolism—NT5C3A—bone cancer	0.00172	0.00293	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—JUN—bone cancer	0.00172	0.00293	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—RGS1—bone cancer	0.0017	0.00289	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—GRM4—bone cancer	0.0017	0.00289	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—BRAF—bone cancer	0.00168	0.00287	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—GRM4—bone cancer	0.00163	0.00278	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—RGS1—bone cancer	0.00163	0.00278	CbGpPWpGaD
Minaprine—MAOA—Metabolism—NT5C3A—bone cancer	0.00162	0.00276	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	0.00159	0.0027	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—SMO—bone cancer	0.00157	0.00267	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—GRM1—bone cancer	0.00156	0.00266	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—RGS1—bone cancer	0.00154	0.00262	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—GRM4—bone cancer	0.00154	0.00262	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—GRM1—bone cancer	0.00147	0.00251	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—bone cancer	0.00147	0.0025	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.00146	0.00249	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—EIF2S1—bone cancer	0.00145	0.00247	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—RGS1—bone cancer	0.00145	0.00247	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—GRM4—bone cancer	0.00145	0.00247	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.00142	0.00242	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—GRM1—bone cancer	0.00142	0.00241	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00141	0.0024	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—MDM2—bone cancer	0.00141	0.0024	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	0.00141	0.0024	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—JUN—bone cancer	0.0014	0.00239	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.0014	0.00238	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—SMO—bone cancer	0.00138	0.00236	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—SMO—bone cancer	0.00136	0.00232	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—SMO—bone cancer	0.00135	0.00231	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—GRM1—bone cancer	0.00134	0.00227	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—CDK4—bone cancer	0.00133	0.00227	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	0.00133	0.00226	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—RGS1—bone cancer	0.00132	0.00224	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—GRM4—bone cancer	0.00132	0.00224	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—CDK4—bone cancer	0.0013	0.00222	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—BRAF—bone cancer	0.00129	0.0022	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—GRM4—bone cancer	0.00128	0.00218	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—RGS1—bone cancer	0.00128	0.00218	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.00127	0.00217	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—GRM4—bone cancer	0.00126	0.00215	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—RGS1—bone cancer	0.00126	0.00215	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—GRM1—bone cancer	0.00126	0.00214	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—RGS1—bone cancer	0.00125	0.00213	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—GRM4—bone cancer	0.00125	0.00213	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—BRAF—bone cancer	0.00121	0.00207	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.00121	0.00207	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.0012	0.00204	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—GRM4—bone cancer	0.00116	0.00198	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—RGS1—bone cancer	0.00116	0.00198	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—GRM4—bone cancer	0.00114	0.00195	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—RGS1—bone cancer	0.00114	0.00195	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—GRM1—bone cancer	0.00114	0.00195	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—RGS1—bone cancer	0.00114	0.00194	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—GRM4—bone cancer	0.00114	0.00194	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—JUN—bone cancer	0.00114	0.00194	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—GRM1—bone cancer	0.00111	0.00189	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—GRM1—bone cancer	0.00109	0.00186	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—GRM1—bone cancer	0.00109	0.00185	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—MDM2—bone cancer	0.00108	0.00184	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	0.00103	0.00176	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—MDM2—bone cancer	0.00102	0.00173	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—GRM1—bone cancer	0.00101	0.00172	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—GNA11—bone cancer	0.001	0.00171	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.001	0.0017	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—SMO—bone cancer	0.000998	0.0017	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—GRM1—bone cancer	0.000992	0.00169	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—GRM1—bone cancer	0.000987	0.00168	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GRM4—bone cancer	0.000965	0.00164	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—RGS1—bone cancer	0.000965	0.00164	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—GNA11—bone cancer	0.000948	0.00161	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—SMO—bone cancer	0.000941	0.0016	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—TP53—bone cancer	0.000926	0.00158	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—GNA11—bone cancer	0.000913	0.00155	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—IL3—bone cancer	0.000911	0.00155	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GRM4—bone cancer	0.00091	0.00155	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—RGS1—bone cancer	0.00091	0.00155	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000898	0.00153	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—GNA11—bone cancer	0.000861	0.00147	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—IL3—bone cancer	0.000859	0.00146	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—JUN—bone cancer	0.000858	0.00146	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NDUFA12—bone cancer	0.000851	0.00145	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—JUN—bone cancer	0.00084	0.00143	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000839	0.00143	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000839	0.00143	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GRM1—bone cancer	0.000837	0.00143	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL3—bone cancer	0.000827	0.00141	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—GNA11—bone cancer	0.000811	0.00138	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—SMO—bone cancer	0.000805	0.00137	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GRM1—bone cancer	0.000789	0.00134	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL3—bone cancer	0.00078	0.00133	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GRM4—bone cancer	0.000778	0.00133	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RGS1—bone cancer	0.000778	0.00133	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ENO2—bone cancer	0.000753	0.00128	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—TP53—bone cancer	0.00075	0.00128	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—GNA11—bone cancer	0.000736	0.00125	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—IL3—bone cancer	0.000735	0.00125	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000724	0.00123	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—GNA11—bone cancer	0.000715	0.00122	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—SMO—bone cancer	0.00071	0.00121	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ENO2—bone cancer	0.000709	0.00121	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—NT5C3A—bone cancer	0.000705	0.0012	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—GNA11—bone cancer	0.000704	0.0012	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—GNA11—bone cancer	0.0007	0.00119	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—SMO—bone cancer	0.000699	0.00119	CbGpPWpGaD
Minaprine—ACHE—Metabolism—DHFR—bone cancer	0.000698	0.00119	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—SMO—bone cancer	0.000695	0.00118	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RGS1—bone cancer	0.000687	0.00117	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GRM4—bone cancer	0.000687	0.00117	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RGS1—bone cancer	0.000676	0.00115	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GRM4—bone cancer	0.000676	0.00115	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GRM1—bone cancer	0.000675	0.00115	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GRM4—bone cancer	0.000672	0.00115	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RGS1—bone cancer	0.000672	0.00115	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL3—bone cancer	0.000667	0.00114	CbGpPWpGaD
Minaprine—MAOA—Metabolism—DHFR—bone cancer	0.000658	0.00112	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GNA11—bone cancer	0.000653	0.00111	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—GNA11—bone cancer	0.00065	0.00111	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—IL3—bone cancer	0.000649	0.0011	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—GNA11—bone cancer	0.000639	0.00109	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—IL3—bone cancer	0.000638	0.00109	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—GNA11—bone cancer	0.000636	0.00108	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—IL3—bone cancer	0.000635	0.00108	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000629	0.00107	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000626	0.00107	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GNA11—bone cancer	0.000615	0.00105	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GRM1—bone cancer	0.000596	0.00101	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—MMP2—bone cancer	0.000594	0.00101	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CYP3A4—bone cancer	0.000592	0.00101	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SMO—bone cancer	0.000589	0.001	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL3—bone cancer	0.000589	0.001	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000589	0.001	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GRM1—bone cancer	0.000586	0.000998	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GRM1—bone cancer	0.000583	0.000993	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL3—bone cancer	0.00058	0.000987	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL3—bone cancer	0.000576	0.000982	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—TP53—bone cancer	0.000567	0.000965	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CYP3A4—bone cancer	0.000558	0.00095	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SMO—bone cancer	0.000556	0.000947	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—TP53—bone cancer	0.000554	0.000944	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GNA11—bone cancer	0.000539	0.000918	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GNA11—bone cancer	0.000508	0.000866	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSTP1—bone cancer	0.000506	0.000862	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ATF1—bone cancer	0.000501	0.000854	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL3—bone cancer	0.000489	0.000833	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSTP1—bone cancer	0.000477	0.000812	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SMO—bone cancer	0.000475	0.00081	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ATF1—bone cancer	0.000473	0.000805	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL3—bone cancer	0.000461	0.000785	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GNA11—bone cancer	0.000435	0.000741	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SMO—bone cancer	0.00042	0.000715	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TGFBR2—bone cancer	0.000418	0.000712	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SMO—bone cancer	0.000413	0.000703	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SMO—bone cancer	0.000411	0.0007	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000404	0.000689	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL3—bone cancer	0.000394	0.000672	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TGFBR2—bone cancer	0.000394	0.000671	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IGF1R—bone cancer	0.000393	0.00067	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GNA11—bone cancer	0.000384	0.000654	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000378	0.000643	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GNA11—bone cancer	0.000376	0.00064	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF1R—bone cancer	0.000371	0.000632	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ATF1—bone cancer	0.000357	0.000608	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ATF1—bone cancer	0.000351	0.000598	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ATF1—bone cancer	0.000349	0.000595	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL3—bone cancer	0.000348	0.000593	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL3—bone cancer	0.000342	0.000583	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL3—bone cancer	0.000341	0.00058	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	0.000337	0.000574	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1R—bone cancer	0.000317	0.00054	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ENO2—bone cancer	0.000309	0.000526	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TGFBR2—bone cancer	0.000298	0.000507	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	0.000293	0.000499	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	0.000291	0.000496	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—DHFR—bone cancer	0.000286	0.000488	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KIT—bone cancer	0.000285	0.000486	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1R—bone cancer	0.00028	0.000477	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1R—bone cancer	0.000275	0.000469	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1R—bone cancer	0.000274	0.000467	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KIT—bone cancer	0.000269	0.000458	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—BRAF—bone cancer	0.000268	0.000457	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GNA11—bone cancer	0.000268	0.000456	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTGS2—bone cancer	0.000262	0.000447	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—EGFR—bone cancer	0.00026	0.000443	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—BRAF—bone cancer	0.000253	0.000431	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTGS2—bone cancer	0.000247	0.000421	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—EGFR—bone cancer	0.000245	0.000417	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CYP3A4—bone cancer	0.000243	0.000414	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KIT—bone cancer	0.00023	0.000392	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MDM2—bone cancer	0.000225	0.000383	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—BRAF—bone cancer	0.000216	0.000368	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MDM2—bone cancer	0.000212	0.000361	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EGFR—bone cancer	0.00021	0.000357	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTP1—bone cancer	0.000208	0.000354	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KIT—bone cancer	0.000203	0.000346	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KIT—bone cancer	0.0002	0.00034	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KIT—bone cancer	0.000199	0.000339	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—JUN—bone cancer	0.000195	0.000333	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—BRAF—bone cancer	0.000191	0.000325	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—bone cancer	0.00019	0.000324	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—BRAF—bone cancer	0.000188	0.00032	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—BRAF—bone cancer	0.000187	0.000318	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—bone cancer	0.000185	0.000315	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—JUN—bone cancer	0.000184	0.000314	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—bone cancer	0.000182	0.00031	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MDM2—bone cancer	0.000181	0.000309	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—bone cancer	0.000181	0.000308	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—bone cancer	0.000179	0.000305	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MDM2—bone cancer	0.00016	0.000272	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—JUN—bone cancer	0.000158	0.000268	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MDM2—bone cancer	0.000157	0.000268	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MDM2—bone cancer	0.000157	0.000267	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—bone cancer	0.000153	0.000261	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—bone cancer	0.000153	0.000261	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—bone cancer	0.000145	0.000247	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—JUN—bone cancer	0.000139	0.000237	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—JUN—bone cancer	0.000137	0.000233	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—JUN—bone cancer	0.000136	0.000232	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—bone cancer	0.000135	0.00023	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—bone cancer	0.000133	0.000227	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—bone cancer	0.000132	0.000225	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—bone cancer	0.000129	0.00022	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—bone cancer	0.000124	0.000211	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—bone cancer	0.000122	0.000207	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—bone cancer	0.000109	0.000186	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—bone cancer	0.000108	0.000183	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—bone cancer	0.000108	0.000183	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—bone cancer	0.000107	0.000182	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—bone cancer	0.000104	0.000177	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—bone cancer	9.18e-05	0.000156	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—bone cancer	9.03e-05	0.000154	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—bone cancer	8.98e-05	0.000153	CbGpPWpGaD
